Don’t miss the new article by Dr. Gemma Navarro and Dr. Rafael Franco about cannabinoid CB1 and CB2 receptors signaling. They have successfully used CELT-335, one of our fluorescent CB1/CB2 receptor ligands, to perform binding competition assays avoiding the use of radioactivity.
See full article: https://www.sciencedirect.com/science/article/pii/S1043661821005545?via%3Dihub